Institutional investors control 2.06% of the outstanding shares in PURE. This represents a greater percentage of ownership than at almost any other company in the Medical Specialties industry. Additionally, during the quarter ended April 2016, these large investors purchased a net $125.3 thousand shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
SENTINEL CAPITAL SOLUTIONS, INC. Sold 50.0 Thousand shares of PURE Biosciences Inc
ESSEX INVESTMENT MANAGEMENT CO. ... Sold 61.7 Thousand shares of PURE Biosciences Inc